TURKISH JOURNAL OF ONCOLOGY 2019 , Vol 34 , Num 3
Evaluation of Factors Affecting Fatigue and Anxiety in Patients with Cancer
Hatice YORULMAZ1,Şeyma KÜRTÜNLÜ1,Çağla TÜRKYILMAZ1,Nermin KARAHALİLOĞLU2,Nalan HACIOĞLU1,Elif YORULMAZ3
1Department of Nursing, Haliç University, School of Nursing, İstanbul-Turkey
2Department of First and Aid Emergency, T.C. Şişli Vocational School, İstanbul-Turkey
3Department of Gastroenterology, Bağcılar Training and Research Hospital, İstanbul-Turkey
DOI : 10.5505/tjo.2019.1826

Summary

OBJECTIVE
The aim of the present study was to evaluate the factors affecting fatigue impact, severity, and anxiety levels in patients with cancer.

METHODS
Data were collected by applying the information form, Beck Anxiety Scale, Fatigue Impact Scale, and Fatigue Severity Scale to 286 patients with cancer. Statistical analysis was performed by t-test, one-way analysis of variance, Tukey analysis, and Pearson"s correlation coefficient.

RESULTS
It was found that 80.1% of the participants were married, 60.8% graduated from primary school, 38.9% were housewives, 62.9% had an average income, 79% had been diagnosed for 6?24 months, 34.3% had adequate information related to illness, and 81.46% had never taken any psychological help. In the study, it was observed that patients who were in the age group of 65-89 age, illiterate, poor economic status, non-working, and those who think that fatigue and anxiety symptoms are the result of treatment suffer from fatigue more severely in their daily live. At the same time, patients who were female, illiterate, tradesmen, had bad economic status, non-working, and with fatigue and anxiety symptoms dependent on treatment had more intense level of fatigue (p<0.05).

CONCLUSION
It would be appropriate to provide different education programs to patients with cancer about fatigue and anxiety by taking into account the group variables.

Introduction

Fatigue, which is seen in patients with cancer, is defined as weakness of muscles, accumulation of waste due to cell destruction, anemia, cancer pathology, cancer treatment, pain, anxiety, disruption of sleeping and resting system, and feeling of an unpreventable exhaustion that is caused by social condition and lifestyle. Fatigue can affect their feelings about themselves, daily activities, and relationships with others and block the treatment period.[1-3] Feeling desperate, being unable to plan for the future because of hopelessness, and negative feelings related to illness and treatment cause anxiety for the future of the palevtient. Moreover, it is thought to affect the patients" life quality negatively. In addition to this, the high price of chemotherapy drugs, the long period of illness, and the loss of employment cause economic problems. Hopelessness, uncertainty, despair, future anxiety, and negative feelings that are experienced related to illness and treatment decrease the life quality of the patient.[4] The fear caused by the word "cancer," anxiety for the future, despair, and expectation of "something bad is going to happen" cause anxiety in the patient. The approaches intended for determining and decreasing the factors affecting anxiety and fatigue influence patients with chronic kidney failure and cancer.[5] "Fatigue Severity Scales" and "Fatigue Impact Scales" are used in cancer and other disease studies abroad. However, in our country, we did not find any studies using these scales in patients with cancer. In the present study, we aimed to examine the impact of socio-demographic and illness-related characteristics on fatigue impact, severity by using "Fatigue Severity Scales" and "Fatigue Impact Scales," and anxiety levels.

Methods

Sampling
The research data were collected from 286 patients with cancer who are under diagnosis for 6 months, who are at least 18 years old, and who are under observation in three education and research hospitals.

Applied Scales and Forms
Descriptive information form, Beck Anxiety Scale (BAS), Fatigue Impact Scale (FIS), and Fatigue Severity Scale (FSS) were applied to patients with cancer.

Beck Anxiety Scale
BAS was translated to Turkish by Ulusoy et al. and is used to determine the frequency of anxiety symptoms. [6] It is a Likert scale consisting of 21 items and contains "no," "low degree," "medium degree," and "serious degree" options. The point interval is 0-63. The Cronbach"s alpha degree of the study has been determined as 0.915.

Fatigue Severity Scale
FSS was developed by Krupp et al. to measure the fatigue severity in patients with multiple sclerosis.[7] The Turkish version of the scale was applied to patients with multiple sclerosis by Armutlu et al.[8] The Cronbach"s alpha value of the study was determined as 0.979. FSS is a Likert scale consisting of nine items. Each item is graded from 1 (I totally disagree) to 7 (I totally agree). FSS point is the average of items. When the average point is ≥5, it is considered as "there is fatigue."

Fatigue Impact Scale
FIS is used to measure the effects of fatigue in daily activities and quality of life. It was developed by Fisk et al. in clinical and experimental studies.[9] The Turkish version of the scale was applied to patients with multiple sclerosis by Armutlu et al.[8] The Cronbach"s alpha value of the study was determined as 0.977 in patients with cancer. FIS is a Likert scale consisting of 40 items. Each item is graded between 0 and 4. The effect of fatigue is considered as none, a little, mid important, and very important.

Statistical Analysis
Data were analyzed using t-test, one-way analysis of variance, Tukey analysis, and Pearson's correlation coefficient.

Results

The average age of the samples was 54.01±15.17 years. It was seen that the sample group comprised 24.1% with lung cancer, 18.9% with breast cancer, 16.1% with colon cancer, 7.3% with uterus cancer, 9.1% with stomach cancer, and 24.5% with other cancer types. The average points of the patients were 18.48±13.75 for BAS, 57.98±39.91 for FIS, and 5.30±1.8 for FSS. It was observed that patients aged between 65 and 89 years had higher scores than patients aged between 46 and 64 years (p<0.05). It was observed that female had higher scores than male patients (p<0.01). No significant differences due to marital status were observed in three scales (p>0.05). It was observed that illiterates had higher points (p<0.01) than high school graduates (p<0.001) and undergraduates (p<0.01) for BAS. It was observed that illiterates had higher points (p<0.001) than high school graduates (p<0.001) and undergraduates (p<0.01) for FIS. It was observed that illiterates and primary school graduates had higher points (p<0.05) than high school graduates (p<0.05) for FSS. It was observed that tradesmen had higher points than housewives (p<0.05).

Patients from lower economic levels had higher scores (p<0.05) than those from middle and better economic levels (p<0.05) for BAS. Patients from lower economic levels had higher scores (p<0.01) than those from better economic levels (p<0.001) for FIS. Patients from lower and middle economic levels had higher scores (p<0.01) than those from better economic levels (p<0.001) for FSS. Unemployed patients had higher scores than employed patients (p<0.05) for BAS.

According to the diagnosed and treatment periods, having informed about the illness, level of information about the illness, and having psychological help, there was no significant difference (p>0.05) from all scales.

It was observed that patients who thought that fatigue and anxiety were caused by treatment had higher points than those who did not have the same opinion (p<0.01) for BAS and FIS. Patients who thought that fatigue was caused by treatment had higher points than both those who thought that fatigue was partially caused by treatment (p<0.001) and those who thought fatigue was not caused by treatment (p<0.01). Patients who received radiotherapy had higher points than those who did not (p<0.05) for FIS. Patients who did not have an operation had higher points than those who had an operation (p<0.05) for FIS< (Table 1, 2, 3).

Table 1: The analysis results done among socio-demographic- and disease-related variables and BAS

Table 2: The analysis results done among socio-demographic- and disease-related variables and FIS

Table 3: The analysis results done among socio-demographic- and disease-related variables and FSS

Discussion

In the present study, it was seen that patients with cancer had medium anxiety level, they were tired, and this fatigue impacted their daily lives. Fatigue is a common symptom seen in all cancer treatments, and there are multiple relationships between treatment type, dose, side effects, and fatigue.[10-12] The severity of fatigue felt by patients and its effects on the patient changes depending on several environmental and individual factors.[13] It was determined that the 19-45 and 46-64 age groups had low anxiety level, whereas the 65-89 age group had medium anxiety level. Moreover, patients in each group were generally tired. Fatigue has a low level effect on the daily life of the 19-45 age group, whereas it has a medium level effect on the 65-89 age group. Tralongo et al. determined that patients who are aged ≥65 years with cancer complained about fatigue more than others.[14] Getting older and the fear of death because of the disease process may cause an increase in anxiety level. Female patients had medium anxiety level, whereas male patients had low anxiety level. Scheier et al. reported that female patients have high anxiety level.[15] Fatigue impacts male patients" lives slightly, whereas it affects females" lives moderately. Hwain et al. also indicated that female patients have a more significant fatigue level.[16] This may be because of women having more responsibilities, such as housework and children, among others. Single and married patients have moderate anxiety levels, they are tired, and their tiredness affects their daily lives moderately. According to Dedeli"s study, social support is beneficial, and there is a positive relationship between the family members" emotional support and patients" wellness.[17] A social support that will be given may decrease the fatigue and anxiety levels of married and single patients.

We observed that illiterate patients had moderate level of anxiety. Illiterate patients" lives were affected moderately by tiredness, whereas others were affected slightly. Loge et al. indicated that tiredness increases when education level decreases.[18] Low-educated patients correlate their viewpoint through cancer with death, and this may cause an increase in anxiety level. Tradesmen had moderate anxiety level, whereas patients from other professions had low anxiety level. Fatigue has moderate effect on tradesmen, whereas it has a slight effect on patients from other professions. Tradesmen have to struggle not only at home but also at work, and this may increase anxiety and fatigue. Patients with low economic levels had moderate anxiety levels, whereas patients with medium and good economic levels had low anxiety levels. Economic problems are important factors that complicate getting over with the illness.[19] It was determined that employed patients had low anxiety level, whereas unemployed patients had medium anxiety level. In the present study, fatigue affected all patients" lives slightly, and employed patients were not tired, whereas unemployed patients were tired. Curt et al. stated that patients with cancer have fatigue after diagnosis, and that 75% of them have to change their jobs because of fatigue.[20] Patients who had 6-24 months of diagnosis had low anxiety level, and patients with 2-5 years and ≥5 years of diagnosis had medium anxiety level. Cancer diagnosis and treatment may cause harm in the patient"s quality of life, psychological situation, and patient"s adaptation to illness. Beser and Oz reported that anxiety and depression increase during the treatment and illness periods and affect the patient's quality of life negatively.[10] Lampic et al. stated that patients with cancer diagnosis have difficulty in adapting the illness and treatment periods, and that they cannot meet their social needs. [21] This situation may cause anxiety in patients. In our study, patients in all groups were tired, and tiredness affected their lives slightly. Fatigue may reduce physical adequacy and handicap social relationships.[22]

Patients with adequate information related to illness had low anxiety level, whereas those without information had medium anxiety level; both groups were tired, and tiredness affected their lives slightly. Armay et al. stated that the patients" level of knowledge about the illness may determine their responses.[23]

Sufficiency of information may enable to overcome the illness, remove catastrophic conception, and have positive effects on responses about the illness. It may be thought that patients having been educated about the illness and knowing how to overcome it may be effective in decreasing fatigue. Barcevick et al. determined that a program on avoiding energy wasting and activity management has an effect on decreasing fatigue.[24] Patients with and without psychological help had medium anxiety level; patients in both groups were tired, and tiredness affected their lives slightly. It is important to consider the effects of medicines on fatigue and sleep. Patients who thought that anxiety was caused by treatment and those who had the opposite idea had medium anxiety level. Patients who thought that fatigue and anxiety were partially caused by treatment had low anxiety level. According to the FSS, patients who thought that fatigue and anxiety were caused by treatment were tired, but the other group was not. Pınar et al. determined that patients with cancer not only have symptoms caused by the illness period but also have anorexia that was a side effect of radiotherapy and physical and emotional symptoms, such as cachexia, taste differences, nausea-vomiting, fatigue, depression, and anxiety.[25] We did not observe an important difference on anxiety level between patients who had chemotherapy and who did not. Patients who had chemotherapy were not tired. Beser and Oz stated that patients who are worried about their future have an increase anxiety level after chemotherapy.[10] The uncertainty of the chemotherapy period and the negative effects of the side effects of chemotherapy may cause anxiety in patients with cancer. Curt et al. stated that fatigue is the most common side effect in patients who have chemotherapy. Fatigue affected the daily lives of patients with radiotherapy more than those who did not. The physiological changes in all treatment periods may cause anxiety and anxiety-related fatigue in patients.[20] Patients who had an operation had low anxiety level. The effect of fatigue on patients who had an operation may be because of the long recovering period.

Conclusion

According to the results of our study, it is thought that fatigue was caused by socio-demographic and other illness-related variables more than treatment types. Fatigue in patients with cancer may occur because of several reasons, such as socio-demographic, illness-related characters, and physiological factors. Education programs that would be prepared with taking these variables into account could considerably affect anxiety and fatigue levels.

Peer-review: Externally peer-reviewed.
Conflict of Interest: No conflict of interest.
Ethics Committee Approval: Provincial Directorate of Health of İstanbul. 25/2015.
Financial Support: None declared. Authorship contributions: Concept - E.Y., H.Y.; Design - H.Y.; Supervision - E.Y., H.Y.; Materials - Ş.K., Ç.T., N.K., N.H.; Data collection &/or processing - Ş.K., Ç.T., N.K., N.H.; Analysis and/or interpretation - H.Y.; Literature search - Ş.K., Ç.T., N.K., N.H.; Writing - H.Y.; Critical review - E.Y.

References

1) Komurcu S, Senler Cay F. Support, Oncology Handbook. In: Aydıner A, Topuz E, editors. Treatment and Symptom control in Cancer. Istanbul: Turgut Publishing; 2006 pp.80936.

2) Madeya ML, Britton D. Yorgunluk. In: Yasko JM, editor. Inspection and Maintenance Chemotherapy Related Symptoms. İstanbul: Foundation for Scientific and Technical Publications translation, printing and bindery; 1994. pp. 1337.

3) Azak A, Cınar S. Fatigue Syndrome In Patients With Lymphoma (Hodgkin And Non-Hodgkin) and Influencing Factors. THOD 2005;15(2):7883.

4) Oz F. Uncertainty in Illness Experience. Turkish J Psychiatry 2001;12(1):618.

5) Marrs JA. Stress, fears, and phobias: the impact of anxiety. Clin J Oncol Nurs 2006;10(3):31922.

6) Ulusoy M, Şahin NH, Erkmen H. Turkish version of the Beck Anxiety Inventory: Psychometric properties. J Cogn Psychother 1998; 12(2):16372.

7) Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigure in multipl sclerosis. Arch Neurol 1988;45:4357.

8) Armutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI, Guney Z et al. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res 2007;30(1): 81-5.

9) Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994;21(1):914.

10) Beser N, Oz F. Anxiety-depression level and Quality of Life the Patients with Lymphoma who are Curing with Chemotherapy. J Cumhuriyet University 2003;7:4758.

11) Arıkan K. Psychological Support in Cancer Patients. Clinic Development 2004;17(1):7786.

12) Alhberg K, Ekman T, Gaston-Johansson,F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet 2003;362 (9384):64050.

13) Carpenito LJ. Nursing Diagnosis: Application to Clinical Practice. 9th Edition, J.B. Philadelphia: Lippincott Company; 2002. p. 51215.

14) Tralongo P, Respini D, Ferrau F. Fatigue and aging. Crit Rev Oncol Hematol 2003;48(Suppl):S5764.

15) Scheier AM, Williams SA. Anxiety and Quality of Life of Women Who Receive Radiation or Chemotheropy for Breast Cancer. Oncol Nurs Forum 2004; 31(1):12730.

16) Husain A, Stewart K, Arseneault R, Moineddin R, Cellarius V, Librach S, et al. Women experience higher levels of fatigue than men at the end of life: A longitudinal home palliative care study. J Pain Symptom Manage 2009;33(4):38997.

17) Dedeli Caydam Ö. Fadıloğlu Ç, Uslu R. A survey of functional living and social support in patients with cancer. Turkish J Oncology 2008; 23(3):1329.

18) Loge JH, Abrahamsen AF, Ekeberk Q, Kaasa S. Hodgkin"s disease survivors more fatigued than the general population. J Clin Oncol 1999;17(1):25361.

19) Donovan KA, Jacobsen PB, Andrykowski MA, Winters EM, Balducci L, Malik U, et al. Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manage 2004;28(4):37380.

20) Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, et al. Impact of cancer-related fatigue on patients: new findigs from the Fatigue Colalition. Oncologist 2000;5(5):35360.

21) Lampic C, von Essen L, Peterson VW, Larsson G, Sjödén PO. Anxiety and depression in hospitalized patients with cancer: agreement in patient-staff dyads. Cancer Nurs 1996;19(6):41928.

22) Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, et al. Patient, caregiver and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey The Fatigue Coalition. Semin Hematol 1997;34 (3 Suppl 2):412.

23) Kocaman N. Ozkan M, Armay Z, Ozkan S. The reliability and the validity study of Turkish adaptation of the revised Illness Perception Questionnaire. Anatolian Journal of Psychiatry 2007;8:27180.

24) Barsevick AM, Whitmer K, Sweeney C, Nail LM. A pilot study examining energy conservation for cancer tretment-related fatigue. Cancer Nurs 2002;25(5):33341.

25) Pınar G, Algıer L, Colak M, Ayhan A. Quality of Life in Patients with Gynecologic Cancer. International J Hematology and Oncology 2008;18(3):1419.